Namocatcat, Marites G.

HRN: 09-47-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/12/2025
02/19/2025
IV
600mg
Q6
DM Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: